How can a vaccine passport be accepted but proof of antibody/immunity rejected?
  • Given the vaccination objective is to get the immune system to work up antibodies against exposure to Sars-COV2, why’s there no tracking of antibody response in those who’ve been vaccinated, those who’ve recovered from Covid-19, etc?
  • Shouldn’t that be the basis for vaccine need?
  • Wouldn’t it also create a non-judgmental way to encourage vaccine hesitant to get the shot?


Why is coronavirus testing basic, limited and disorganised?

Why is there no distinction – especially in testing – between SARS-Cov2 and Covid-19?

  • The former is the virus, susceptible to antivirals and prevention measures.
  • The latter is the immunological consequence and requires hypoxia and biochemical and immunological indicators (CRP, D-Dimer etc).
  • Why are these still blurred together?

Heading towards the third year of the Coronavirus pandemic:

  • Why has there been so little emphasis and progress on testing?
  • Rapid testing, rapid results, judiciously placed, free of charge, have demonstrable benefits with no downside except cost to government.
  • Why is there no coherent testing infrastructure?
  • Polling shows even the vaccine hesitant are not against regular testing (especially free home testing) which is a less disruptive, less bankrupting policy than adhoc lockdowns.
  • Why is there no pandemic test-and-advise protocol in place despite governments arguing endlessly over mask mandates in schools, vaccinating children, etc?
  • Why do none of the Covid-19 testing include antibody/t-cell scores or variant tracking?
  • Why is a negative Covid-19 test + high natural antibodies score not equivalent or better to vaccination certification?
  • Antibodies/T-Cells score is the measure of vaccine immune system successful response, can’t be faked. Vaccine certificates can be faked and vary wildly person to person even among the vaccinated. It defies logic.
  • Why wasn’t testing focused on antibody levels from the get go – or as soon as possible – as it is effective, useful data before and after vaccination, determines who reacts well, who may need boosters, who’s fought off SARS-Cov2 and gotten high immunity, who may need vaccine despite prior infection; and maybe most important: how SAFE a person is from getting or giving Coronavirus?
What should be included in Covid-19 prophylaxis (prevention)?

Vaccines, obviously. Proper testing and fast response to positive tests. Doctor-prescribed prophylactics. Immunocompromised in particular need a diverse range of prophylactics.

What’s the aim of the entire Covid vaccine (and other preventatives) program?

  • Immunity
  • Antibodies against SARS-CoV2
  • Reduced viral load
  • Shortened infectious periods
  • Less likely to be hospitalised
  • Less likely to die

Vaccination is a way to get some immunity without having to contract the virus (which is risky) to get natural immunity.

  • Recovering from the virus gives 8x-12x level of antibody immunity
  • SARS equivalent immunity has lasted 10+ years
  • mRNA vaccine immunity is shown to wane considerably after 6 months

Proper testing shows up individual immunity-antibodies-resistance to SARS-CoV2. Testing is non-discriminatory.

Anything less than proper testing is increasing risk to public health, perpetuating the virus, potentially contributing to SARS-CoV2 becoming endemic.

What is a reasonable cost-benefit analysis for lockdowns?
  • Impact on spread
  • Impact on mental health
  • Harm to social lives
  • Absolute restriction on freedom versus particular restriction on infected
  • Hit to business
Should vaccination be universal? Does natural immunity match vaccine immunity? Should the young be vaccinated?
  • Universal benefits
  • Young dangers
  • Young risk versus older people risk. Who deserves to take the risk?
  • Myocarditis young – especially young males – incident percentages versus simply catching Covid versus baseline in population

UK government vaccines watchdog rules out Covid jabs for children

“JCVI says there is insufficient evidence to support giving jabs to all 12- to 15-year-olds” but was updated a few hours later to Ministers could defy JCVI and go ahead with Covid jabs for all 12- to 15-year-olds with sub-head “Official vaccine advisers consider margin of benefit too small to support vaccination of entire age group.”


Natural Immunity versus Vaccine Immunity

Vaccinating people who have had covid-19: why doesn’t natural immunity count in the US? (13-Sept-2021)

US as of 11th December 2020:

  • 11-Dec-2020 @ https://web.archive.org/web/20210115184811/https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/burden.html
  • 27-Jul-2021 @ https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/burden.html

US, Natural infection, Feb 2020 to May 2021:

  • 0 – 17     26.8 / 73    37%
  • 18 – 49   60.5 / 138   44%
  • 50 – 64     20.4 / 62    32%
  • 65+ 12.3 / 54    23%
  • Total 120.3/ 328   37%

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection (5-Feb-2021)

Natural infection versus vaccination: Differences in COVID antibody responses emerge (24-Aug-2021)

  • N = 254 blood samples post infection
  • N = 51 long term follow up
  • Antibodies against SARS-CoV2 spike and receptor binding domain (RBD) declined moderately over 8 months
  • Memory B cells against SARS-CoV2 spike increased between 1 month and 8 months after infection
  • Proportion of subjects positive for CD4+ T cells (92%) remained high at 6 to 8 months after infection
  • The different types of immune memory each had distinct kinetics, resulting in complex interrelationships over time
  • Substantial immune memory is generated after COVID-19
  • About 95% of subjects retained immune memory at ~6 months after infection
  • Circulating antibody titers were not predictive of T-cell memory

CDC still recommends a full vaccination dose for all the immune response from vaccination is more predictable antibody responses after infection vary widely by individual. Peter Marks, Food and Drug Administration’s Center for Biologics Evaluation and Research: “We do know that the immunity after vaccination is better than the immunity after natural infection generally the immunity after natural infection tends to wane after about 90 days”

Stakeholder Call – Myocarditis and Pericarditis Updates (29-Jun-2021)

It appears from the literature that natural infection provides immunity, but that immunity is seemingly not as strong and may not be as long lasting as that provided by the vaccine UK covid pass guidelines:

Proof of natural immunity shown by a positive PCR test result for COVID-19, lasting for 180 days after the date of the positive test

Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel (20-Apr-2021)

[https://www.medrxiv.org/content/10.1101/2021.04.20.21255670v1.full.pdf ]

  • Vaccination was highly effective
  • Estimated efficacy for documented infection of 92·8%
  • Hospitalisation 94·2%
  • Severe illness  94·4%
  • Death   93·7% 

Protection from prior SARS-CoV-2 infection:

  • Estimated efficacy for documented infection of  94·8%
  • Hospitalisation 94·1%
  • Severe illness  96·4%

Ministry of Health during summer surge:

  • Between 5 July and 3 August (over half a million infected but unvaccinated)
  • Just 1% of weekly new cases were in people who had previously had covid-19 (99% natural immunity)

Dvir Aran, biomedical data, Technion – Israel Institute of Technology: “These numbers look very low. The data suggest that the recovered have better protection than people who were vaccinated.”

Systemic side-effects were more common in people previously infected >>

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study (7-Jul-2021)

Large UK study of systemic/vaccine side effects after natural infection:

  • 1·6 times after the first dose of ChAdOx1 nCoV-19
  • 2·9 times after the first dose of BNT162b2
  • 56% more likely to experience a severe side effect that required hospital care 

Public health strategy versus individualised medicine ideally should blood test every individual, give every individual antibody test, B-cell and T cell test to give an “immunity” score to see if booster is needed

Why is aspirating not mandatory in US/UK/most of the EU?

Aspirating ensures vaccination goes intramuscular, not intravenous. Intravenous is dangerous. Intravenous doesn’t happen often but it is more common in younger people. It could be the reason for the myocarditis, thrombosis and other extreme adverse reactions to the mRNA vaccines in particular.

Table of Contents


Why no public health messaging on tackling known comorbidities like weakened immune system or obesity etc?
Why is there zero definitive info on medical prophylaxis, individual prevention, evolving treatment protocols?
  • Much talk about cases of damage from the spike protein post-vaccine but reasons have been hard to pinpoint. Could it be down to not asperating the needle prior to injection, and thus occasional inadvertent injection of the vaccine into the bloodstream – which is known to be extremely dangerous? How many who’ve had the vaccine got their needles asperated?
  • Why would there be aggressive, partisan exclusion of ANY prophylactic that’s cheap and universal and proven safety record? Amplifying overdose victims is propagandist; never sincere.
  • Consider: vaccine gives (high estimate) 90% protection from SARS-Cov2, ivermectin prophylactic + treatment inclusion adds 0%-5% protection (i.e. it is useless or it is a bit useful). End result potentially saves tens of thousands of lives WITH the antiviral versus without. Where’s the medical logic in banning it?
18+ months into pandemic, how can there be no definitive public health protocols for mask use or thorough study data on mask and viral load?
  • Why have there been no substantial mask studies? Why has that been allowed to be a merely political rather than organized medical issue, regardless of which ‘team’ is in power?
  • There should surely be no uncertainty about these basic issues. The next pandemic may be worse.
  • A Review of the Evidence: Studies of Mask Efficacy – Do Masks Work? (22-Aug-2021)
Why did initial Pfizer/Moderna/AZ interim press releases define vaccine efficacy with no follow-up, no honest developing analysis?
  • The initial vaccine trials, especially for Pfizer and Moderna, showed almost 100% efficacy but the real world has revealed lower efficacy and decreasing efficacy just 6 months into vaccination programs. Why is this acceptable, when non-mRNA vaccines don’t degrade this way?
  • The trial efficacy numbers for the vaccine phase 3 were extrapolated from, ultimately, just a few dozen cherry-picked subjects. How does  efficacy factor in time and viral load, i.e. spending more time coming into contact with SARS-CoV2, being exposed to higher viral load?
  • Vaccine trials pre-published their efficacy numbers after a few weeks phase 3 test subject data. Why were there no follow-up on those subjects involved in the various phase 3 trials, no ongoing testing status?
Why is AstraZeneca ad-vector vaccine not available in America, despite 1B+ doses, longer lasting efficacy at <10% cost-per-dose?

Why is AstraZeneca vaccine not available in the US, even after its proven safe, used in comparable countries with better Coronavirus outcomes?

Why so little attention given – especially from Summer 2021 – to data showing the ad-vector vaccine antibody response is lasting considerably longer than the Pfizer/Moderna mRNA shots?

Is the rapid loss of Covid antibody/immunity from mRNA vaccines contributing to the persistent and otherwise inexplicable low fidelity testing standards?


What's the story with Merck developing both Ivermectin and Molnupiravir?
  • Why is Merck putting billions into researching a new prodrug (molnupiravir) patented high profit antiviral, when it produces Ivermectin already with similar benefits; and could easily have done both?
  • What other explanation can there be for not promoting existing treatments except profit chasing at the expense of human life health?


Antiviral medication Ivermectin was invented in Japan and mass-produced by Merck. It is now out of patent, cheap and available worldwide. Merck is developing Molnupiravir (MK-4482) as a therapeutic to treat COVID-19 infections. It would be an antiviral, like Ivermectin, but patented and therefore potentially worth tens of billions profit versus Ivermectin which is worth nada. Molnupiravir is in Phase 3 trials. Merck received a base award amount of $1.2 billion on 7-Jun-2021 from the Federal Government (1.7 million doses).


PDF DOCUMENT: Molnupiravir versus Ivermectin download


Not surprisingly, the two antivirals have certain similarities. With neither showing any serious adverse side effects. “Molnupiravir is a pro-drug of the novel active antiviral nucleoside analogue … It’s a broad spectrum antiviral agent. … Ivermectin is a broad-spectrum, anti-parasitic, antibiotic and which has demonstrated broad-spectrum antiviral activity.”

Merck had the patent on Ivermectin until 1996. So it is not a coincidence that they have developed this very expensive drug, Molnupiravir, funded by the US taxpayer and which is similar. It follows, then, why there is so much disparagement of Ivermectin. If widely accepted, it could rain on Merck’s parade and greatly embarrass BARDA.

What I cannot grasp is that for the 10 months when the vaccines were being developed, certain caring, critical care physicians sought out existing drugs and developed protocols. These have been changed multiple times and are currently undergoing more changes to address the variants issue. The FLCCC Alliance recommends the use Ivermectin as part of more expansive protocols which they have developed for the prophylaxis and treatment of COVID-19 at all stages by both the vaxxed and the un-vaxxed. These physicians should be lauded, not abused.




  • There are still many nations where vaccines are not yet widely available.
  • There is a gradual shift in focus, to antiviral drugs.
  • Two ways to get new drugs:
    1. Develop novel antiviral drugs for SARS-CoV-2
    2. Repurpose existing FDA-approved drugs to treat COVID-19
  • Ivermectin (by Merck Pharmaceuticals) is the most studied “repurposed” medication globally in randomized clinical trials, retrospective studies and meta-analyses
  • Molnupiravir is a new prodrug antiviral developed by Merck Pharmaceuticals and currently in the pipeline for authorisation as a SARS-CoV2 prophylaxis and treatment


Both Molnupiravir and Ivermectin have demonstrable adjunctive chemoprophylaxis but with no profit from generic Ivermectin, funding from Merck is directed to produce FDA-simpatico studies demonstrating Molnupiravir’s efficacy.


Current trials are ongoing for use of Molnupiravir for:
  • Active treatment of new SARS-CoV-2 infections
  • Post-vaccination breakthrough COVID-19 cases


Molnupiravir and Ivermectin Pharmacokinetics – Pharmacodynamics:
  • Molnupiravir is a broad spectrum antiviral agent against SARS-CoV-2, SARS-CoV, seasonal or pandemic influenza and MERS corona virus
  • Ivermectin is an FDA-approved, WHO essential drug used as broad spectrum antiparasitic, antibiotic, and which has demonstrated broad spectrum antiviral activity against RNA viruses, including HIV, Zika, MERS and Coronavirus
  • FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
  • 5000-fold inhibition of SARS-CoV-2, (99.98% at 48 hours)
  • The inhibitory concentration IC50 of Molnupiravir shows it to be an even more potent anti-SARS-CoV-2 agent, compared to Ivermectin in vitro
  • Both Molnupiravir and ivermectin are well absorbed after oral dosing
  • Tmax of Molnupiravir being 1-1.75 hours, with a half life of 7 hours
  • Tmax of Ivermectin is 4-6 hours, very long half life of 81-91 hours
  • Ivermectin, being lipophilic has a large volume of distribution
  • Ivermectin has the ability to accumulate in the lungs where SARS-CoV2 is most dangerously concentrated
  • Anti-SARS-CoV-2 actions of Molnupiravir and Ivermectin are dose and concentration dependent
  • Molnupiravir active metabolite (NHC-5 Triphosphate) acts as a competitive alternative substrate for viral RNA causing viral mutagenesis or mutations, which leads to viral error catastrophe and extinction of replication
  • There is some concern about the safety of NHC -nucleoside triphosphate, which is also mutagenic to mammalian cells
  • Ivermectin, multifarious actions, binding to SARS-CoV-2 spike protein, reducing cell entry via human ACE2 receptors, reducing viral transcription
  • Complimentary pharmacokinetics and pharmacodynamics of the drugs may be additive or synergistic.
  • This should be further investigated in anti-SARS-CoV-2 antiviral combination therapy e.g. a combination of Molnupiravir with Ivermectin putatively, in effects on RdRP or cytokine release


Molnupiravir/Ivermectin Costs
  1. Cost of Ivermectin package of 100 tablets of 3mg is $2.96, e.g. 12mg per day for 5 days = $0.53
  2. Cost of Molnupiravir to be negotiated separately with national health services but US govt initial purchase worked out at $700 for the equivalent 5 day course


  • Merck says COVID-19 pill cuts risk of death, hospitalization (2-Oct-2021)
  • Molnupiravir, an Oral Antiviral Treatment for COVID-19 (17-Jun-2021)
  • The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID) (28-May-2020)
  • Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) (5-Oct-2020)
  • Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses (26-Aug-2020)
  • Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template (29-Apr-2021)
  • Lab reveals how an oral antiviral drug confuses the replication machinery of SARS-CoV-2 (11-May-2021)

    • Rick Bright – Merck – BARDA – Dr Cadlich – Cronyism
    • Molnupiravir – HHS official documents – Emergency use authorisations for vaccines
    • Ridgeback Pharma funding – Delayed development – Merck buying up Ridgeback’s Molnupiravir after sidelining Ivermectin
    • FDA authorisations for mRNA vaccine factor | Merck with billions in the balance
    Should young people (including children) be vaccinated against SARS-CoV2 - for their own sake, or for reduced transmission?

    Young people recover fast.

    Young males risk greater from mRNA vaccination than from Covid-19.

    Should young people be forced to take the individual risk for the sake of older, vulnerable members of the public?

    Big Picture

    How should Covid-19 be handled, by government and/or public health authorities?
    • Why is government official guidance allowed to devolve into such useless disingenuous binaries?
    • Vaccine versus anti-viral is a case in point. It’s not an either vaccination or antiviral/alternative treatment.
    • Excluding doctor-patient informed free choice makes fait accompli of outlier overdose while excluding billions (including those with no vaccine access).
    • Why is there so much pressure on the vaccine hesitant, but never even an offer of free aftercare in the event of adverse reaction?
    • Why is there no quid pro quo support for workers who submit to testing and adhere to restrictions if infected (e.g. self-isolating), to cover loss of essential earnings?



    Former HHS officials say they tried to accelerate funding for what became Merck’s new “miracle” drug last year, but were blocked. How culture-war stupidity may have cost “tens of thousands” of lives.

    Why has public health been allowed to degenerate into divisive authoritarian binaries?
    • Vaccines, obviously. Doctor access. Prophylactics. Hospital access for all. Monoclonal antibodies, ivermectin and other antivirals, dexamethasone (steroids), etc. Full and open exchange of information alongside all public health decisions. Most of all proper testing.

      The goal of public health response to the novel coronavirus is immunityantibodiesbroad-spectrum resistance to SARS-CoV2. Including access to doctors, hospitals, proper treatment protocols, definitive healthspan advisories.

      • Vaccination is a way to get some immunity without having to contract the virus (which is risky) to get natural immunity.
      • Recovering from the virus gives 8x-12x level of antibody immunity
      • SARS equivalent immunity has lasted 10+ years
      • mRNA vaccine immunity is shown to wane considerably after 6 months
      • People’s bodies respond differently to vaccines and to the virus too
      • Proper testing shows up individual immunity-antibodies-resistance to SARS-CoV2
      • Testing is non-discriminatory.

      Anything less than proper testing is increasing risk to public health, perpetuating the virus, potentially contributing to SARS-CoV2 becoming endemic.

      • What justification can there be for the vaccine mandates, vaccine passports and compelling businesses to check customer passports; but no testing protocol, no testing standard, no logical, responsible public health strategy?
    How is Big Pharma funded, from innovation to development, trials and final product?
    • Why are new technologies like vaccine development largely funded by taxpayer spending, yet all profit goes to the shareholders of the pharmaceutical corporations? Why is public health emergency subordinated to this upward wealth transfer profit dynamic, rather than the other way around?
    Is it possible for Big Pharma profit to coexist with best public health outcomes?
    If vaccine take-up is a public good, can demonizing meds like Ivermectin justified?
    Why is an anti-viral like Ivermectin pilloried as a “horse paste” – in such a blatantly propagandist, divisive way – despite its clear usefulness as a prophylactic, where it simply does what it’s proven to do, BEFORE mid/late stage infections take hold? Some cite lack of quality data on anti-virals like Ivermectin as a reason for its aggressive exclusion from Sars-COV2 protocols. But then why wasn’t Ivermectin trial’d aggressively from early 2020, given it is cheap, readily available and proven to have an exemplary safety record in humans (e.g. against river blindness, dengue, etc)?


  • Ivermectin: How false science created a Covid ‘miracle’ drug
  • Covid antiviral pill can halve risk of hospitalisation
  • American Medical Association (AMA), American Pharmacists Association (APhA), and American Society of Health-System Pharmacists (ASHP) Strongly Oppose the Ordering, Prescribing, or Dispensing of Ivermectin @ AMA Press Release on ama-assn.org website.
  • Why ivermectin should not be used to prevent or treat COVID-19 (2-Sept-2021)
      • Australian government pronounces on Ivermectin via new Australia Medical Association rules for all doctors. AMA rules specifically target doctors, restricting their prescribing, rather than citizens who may be buying antivirals on the black market. I doubt this new ruling will reduce illegal Ivermectin import. If anything the AMA dictates will push doctors and patients further apart, making the latter more likely to resort to self-prescribing, more likely to use social media for dosages, causing worse outcomes. The medically honest policy would’ve been to encourage the doctor-patient relationship by not mistrusting the medical experts and not alienating the patients. This would save lives by freeing doctors to nurture trust in vaccines (by recommending them) while antivirals or other additional interventions get prescribed (or not) under safe supervision.
    Is there vaccine apartheid in rich v poor nations re: mRNA versus ad-vector availability?
    Why has public trust in government/media coronavirus messaging broken down? How can it be restored?

    Authoritarian binaries.

    Dictatorial celebrity front men like Dr Fauci, with compromised (or even corrupt) conflicts of interest.


    Can the end justify the means when it come to public health, i.e. saving the most lives versus respecting individual freedom (to be wrong)?

    Can the end justify the means when it come to public health, i.e. saving the most lives versus respecting individual freedom (to be wrong)?



    Coronavirus Articles and Background Reading

    coronavirus articles

    All | # F U
    There are currently 16 coronavirus articles in this directory
    1-Sept-2021 @ Clinical Trials Meta Search: Ivermectin

    Results and Latest Published/Pre-Published US Clinical Trials – Meta Search: Ivermectin + Covid-19 @ Search Results for official government authorized trials.

    16-Mar-2020 @ SARS-CoV-2 and COVID-19: Most Important Research Questions

    SARS-CoV-2 and COVID-19: The Most Important Research Questions (16-Mar-2020) @ NIH.GOV link.

    16-Sept-2021 @ ONS: Coronavirus (COVID-19) latest insights: Antibodies

    Coronavirus (COVID-19) latest insights: 90%+ in UK Antibodies + Vaccinated (16-Sept-2021) @ O.N.S. Data official website.

    17-Aug-2021 @ Nasal Saline Irrigation: Hospitalizations in COVID-19 Randomized to Alkalinization or Povidone-iodine

    Rapid initiation of nasal saline irrigation: hospitalizations in COVID-19 patients randomized to alkalinization or povidone-iodine compared to a national dataset (17-Aug-2021) @ MEDRXIV.org paper website link.

    21-Jun-2021 @ Huge Number of Hospital Workers Still Unvaccinated
    Huge Number of Hospital Workers Still Unvaccinated (21-Jun-2021) @ SITE LINK on vaccines section of webmd.com.

    24-Sept-2021 @ Merck – Owner of Ivermectin – Starts "New" Patent Antiviral Medication Human Trials

    Merck, developer of general antiviral Ivermectin, announcing late stage human trials for a “new” patent medication and oral antiviral drug for COVID-19 (24-Sept-2021) @ ARTICLE on medicalxpress.com pre-publication website.

    4-Aug-2021 @ Expert Reaction to Covid-19 Infection Study

    Expert reaction to the latest fortnightly release on the COVID-19 Infection Survey looking at antibody and vaccination data for the UK (4-Aug-2021) @ LINK to sciencemediacentre.org article.

    6-Jun-2020 @ What Scientists Know About the COVID-19 Virus


    More than 900 pages of materials related to US.-funded coronavirus research in China were released following a FOIA lawsuit by The Intercept (6-Sept-2021) @ ARTICLE LINK on theintercept.com website.

    Finland Open-Source Vaccine Ready 2020 – State Funding Withdrawn 2021?
  • Finnish-developed, open-source coronavirus vaccine nearly ready for testing (8-May-2020) @ https://yle.fi/uutiset/osasto/news/finnish-developed_open-source_coronavirus_vaccine_nearly_ready_for_testing/11342151
  • Finnish researchers introduce nasal spray Covid “vaccine” (8-Mar-2021) @ https://www.eurekalert.org/news-releases/776561
  • Future of Finland’s Covid nasal spray vaccine uncertain (7-May-2021) @ https://yle.fi/uutiset/osasto/news/future_of_finlands_covid_nasal_spray_vaccine_uncertain/11921318
  • Ivermectin nasal spray supposedly on patent by Finnish startup Therapeutica Borealis is UNPROVEN (25-Aug-2021) @ https://monitor7.r7.com/aprovado-nos-eua-um-spray-nasal-com-cloroquina-e-ivermectina-25082021

  • US FDA Advisory Committee: Pfizer Vaccine "Booster" Meeting

    Vaccines and Related Biological Products Advisory Committee meeting to discuss Pfizer-BioNTech’s supplemental Biologics License Application for administration of a third dose, or “booster” dose, of the COVID-19 vaccine, Comirnaty, in individuals 16 years of age and older


    Pandemic Comments and Docs

    pandemic comments

    All | # A B D E F H I M O R U V W
    There are currently 21 pandemic comments in this directory
    COVID-19 Antibody Responses: Natural Infection Versus Ad-Vector/mRNA Vaccination

    Natural infection versus vaccination: Differences in COVID antibody responses emerge (24-Aug-2021) @ Study Analysis on rockefeller.edu website.

    The Race to Understand Post–COVID-19 Conditions (31-Aug-2021) @ ACP Journal Link on acpjournals.org website.

    A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity (13-Jul-2012) @ ARTICLE on journals.plos.org website.

    Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike Immunogen: induces potent humoral and cellular immune responses (28-Sept-2020) @ NATURE ARTICLE on nature.com website. See interesting ethics declaration at the end of the article.

    Adenoviral vectors are the new COVID-19 vaccine front-runners: Can they overcome their checkered past? (12-May-2020) @ ACS HYPE ARTICLE on cen.acs.org website.

    Chimpanzee adenoviral vectors as vaccines for outbreak pathogens (30-Oct-2017) @ Peer-Reviewed Article on nih.gov repository.

    Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment (18-Sept-2020) @ STUDY RESULTS on sciencedirect.com website.

    News – Communicating the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine (7-Apr-2021) @ Winton Centre Summary on University of Cambridge website.

    Review of COVID-19 vaccine subtypes, efficacy and geographical distributions (8-May-2021) @ PRE-PUBLISH ARTICLE on BMJ (British Medical Journal) website.

    17-Jun-2005 | 22-Aug-2005 | 19-Aug-2008 | 5-May-2018 | 7-Nov-2018 | 16-Mar-2021 | 21-Jun-2021 | 24-Sept-2021 | Various Dodgy Covid-19 Documents

    26-Feb-2015 @ Seguro Popular: Health Coverage For All in Mexico

    Seguro Popular: Health Coverage For All in Mexico (26-Feb-2015) on the World Bank website.

    Antiviral Ivermectin In Africa Blocking COVID-19

    August 2021 report on Ivermectin In Africa Blocking COVID-19 on paulcraigroberts.org blog website. Poorer countries are denied access to the vaccines produced in rich nations. Many must tackle Coronavirus using prophylactics and treatment protocols repurposing existing methods like antivirals.

    DEBUNKED: Coronavirus and Blood Donation by American Red Cross – Pfizer, Moderna, J&J, AstraZeneca ALL Eligible (Aug-2021)

    What to know about the Coronavirus and Blood Donation by American Red Cross (Aug-2021) @ Red Cross Website Link.

    “In most cases, there is no deferral time for individuals who received a COVID-19 vaccine as long as they are symptom free and feeling well at the time of donation. There is no deferral time for eligible blood donors who are vaccinated with an inactivated or RNA based COVID-19 vaccine manufactured by AstraZeneca, Janssen/J&J, Moderna, Novavax, or Pfizer.”

    Delta’s Extra $200 Monthly Healthcare Surcharge To Unvaccinated Airline Workers May Have Serious Unintended Consequences

    Profit Squeeze and Cost Distribution For and Against Vaccine Hesitant and Covid-19 ‘Freeloaders’ – Delta’s Extra $200 Monthly Healthcare Surcharge To Unvaccinated Airline Workers May Have Serious Unintended Consequences (28-Aug-2021) @ ARTICLE on the pro-corporate forbes.com website.

    Digital COVID-19 Social Response in Kinshasa (8-Sept-2021)

    Cash and the city: COVID-19 digital social response in Kinshasa, DRC (8-Sept-2021) @ STUDY LINK on Brookings Institute website.

    Dr. Tess Lawrie: The Conscience of Medicine (4-May-2021)

    Early Pandemic Voluntary Insurance Coverage: Cost-sharing Waivers and Premium Relief in US Healthcare

    Cost-sharing waivers and premium relief by private plans in response to COVID-19 in the Early Pandemic (19-Nov-2020) @ SUMMARY ARTICLE on the healthsystemtracker.org website.

    From August/September 2021: Will Health Insurance Cover COVID-19 Vaccine, Treatment, Adverse Effects, Hospitalization?

    Will My Health Insurance Cover a COVID-19 Vaccine? (29-Aug-2021) @ ARTICLE on the verywellhealth.com website.

    Hospitalisations in England 1-Feb-2021 to 29-Aug-2021
    9,472 people were admitted to English hospitals with the highly transmissible Delta variant of coronavirus between 1 February 2021 and 29 August 2021. 5,098 people were under 50. Some 3,742 – or 73 per cent – of the under 50s were unvaccinated. Over 70% of the over 50s were vaccinated.

    Is it OK to put young lives at greater risk for the sake of older lives potentially facing greater risk, e.g. coronavirus caught by grandkids passed on to grandparents?

    CDC data shows very very low risk from Coronavirus vaccines (mRNA or ad-vector) though the chance of serious side effects increases – separate to co-morbidities – for much younger patients, especially males under 21. CDC site numbers give between 5000-1 and 20000-1 serious myocarditis/pericarditis risk for mRNA (Pfizer/Moderna) vaccines, especially after second dose. This risk is far higher than the risk of serious Covid-19, for that age/gender group. Is it OK to put young lives at greater risk for the sake of older lives potentially facing greater risk, e.g. coronavirus caught by grandkids passed on to grandparents?

    Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA Vaccines in Ontario: December 13, 2020 to August 7, 2021 @ Canada Study of 100 Youths Hospitalized after mRNA Vaccination publichealthontario.ca website link.

    Merck’s deadly Vioxx playbook, redux: a debunked smear campaign against its competing drug — Ivermectin (7-Sept-2021)

    “Vioxx” is the name is a smear campaign playbook used by Merck Pharmaceuticals to campaign against its own competing drug—the FDA-approved, Nobel prize-winning antiviral Ivermectin, which is generic, cheap and globally available with very little scope for significant profit. See Merck’s deadly Vioxx playbook redux (7-Sept-2021) @ ARTICLE on TrialSiteNews website documenting corporate malfeasance.

    Oxford University: Fungus-derived Anti-cancer Drug Shows Promise

    Reddit Thread Capture from /r/Coronavirus – The Days of Full Covid-19 Coverage Are Over

    The Days of Full Covid-19 Coverage Are Over (20-Sept-2021) @ Reddit Thread from /r/Coronavirus subreddit.

    University of North Carolina (Chapel Hill) Announces 3D Printed Vaccine Patch

    3D Printed Vaccine Patch Offers Vaccination Without a Shot (24-Sept-2021) @ University of NC announcement in medicalxpress.com website article.

    US Drug Price Extortion Advocated by Pfizer CEO as Democratic Party Pushes Federal Price Negotiation

    Pfizer CEO rallies staff to fight Democrats’ drug price negotiation (22-Sept-2021) @ ARTICLE on politico.com website.

    VigiAccess gateway to VigiBase: WHO Global Case Safety Database for Medicinal Products
    • VigiBase is the unique WHO global database of individual case safety reports (ICSRs). It is the largest database of its kind in the world
    • VigiAccess launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects of medicinal products

    What’s Gone Wrong in the Fight Against Vaccine Nationalism? Covax Misses 2021 Targets

    Covax Misses its 2021 Delivery Target – What’s Gone Wrong in the Fight Against Vaccine Nationalism? (18-Seot-2021) @ ARTICLE overview on nakedcapitalism.com website.

    Whitney Webb: The Ride of the Biosecurity State on Rokfin

    The Ride of the Biosecurity State – with Whitney Webb on Rokfin (20-Sept-2021) @ ROKFIN VIDEO on Whitney Webb’s Rokfin channel.


    2004 - 2019


    January 2020

    February 2020

    March 2020

    April 2020

    May 2020

    June 2020

    July 2020

    August 2020

    September 2020

    October 2020

    November 2020

    December 2020


    January 2021

    February 2021

    March 2021

    April 2021

    May 2021

    June 2021

    JULY 2021

    AUGUST 2021

    • “In vivo evidence that inadvertent intravenous injection of COVID-19 mRNA vaccines may induce myopericarditis. Brief withdrawal of syringe plunger to exclude blood aspiration may be one possible way to reduce such risk. Both Pfizer/BioNTech and Moderna have clearly stated that their vaccines should only be given via IM route. CDC/UK/WHO guidelines do not instruct this necessary technique.”

    October 2021


    Big Pharma

    mRNA Tech

    Public Health

    NIH (National Institute of Health)

    NIST (National Institute of Standards and Technology)

    NIAID (National Institute of Allergy and Infectious Diseases)

    EIC (European Innovation Council)

    BARDA (Biomedical Advanced Research and Development Authority)


    20+ Years of mRNA Technology Funding

    Development of mRNA technology has been in progress for over 20 years, primarily with a view to opening a new deliver mechanism and drug potential for cancer treatments. Various science hurdles had to be overcome; and NIH / DARPA funding drove the research in the US. UK and German government funding equivalents, both importing the technology once the patented messenger RNA delivered in lipid shell mechanism was patented by US Govt. NIH licensed the mRNA tech to public/private companies like BioNtech, Moderna, Cellscript and others.

    Gain of Function Research

    Gain-of-function research has a long controversial history and by the time Obama administration signed off on American labs not doing it, EU had also banned it. China has no such restrictions on risky leading edge medical research.

    Public Funding - Medical Research and Vaccine Development

    • Coronavirus vaccine development - once SARS-CoV2 pandemic was underway - received acceleration funding from two US federal agencies—the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA).
    • Separate channels of American government-military funding (DARPA) and government-civilian science grants (NIH and Fauci) worked out an evolving gain-of-function research collaboration with the Chinese Communist Party and Wuhan Institute of Virology. Trump administration set up ongoing American support.

    mRNA Technology Development Details

    While mRNA was originally found to be viable for in vivo gene transfer in the early 1990’s, the development of mRNA vaccines was initiated much later due to the inherent instability of mRNA compared to DNA. The efficacy of mRNA vaccines can be increased by several factors, such as ensuring mRNA purity, adding 5’ Kozak and cap sequences, 3’ poly-A sequences and modified nucleosides to increase mRNA stability and decrease detection by the receptors of innate immune cells, codon optimization, introduction by intramuscular, and intradermal injection to reduce RNA degradation, and by generating thermostable mRNA. Methods to encapsulate RNA have also been explored to increase the stability and immunogenicity of RNA vaccines, as has been used with exosome encapsulated RNA and RNA-transfected dendritic cells. When fully optimized, RNA vaccines may have an immunogenic advantage over DNA vaccines due to the presence of multiple cellular pathways that activate innate immunity in response to foreign RNA such as the toll-like receptors (TLRs) and RIG-I-like receptors (RLRs).

    China and American Gain-of-Function Collaboration

    CCP and Chinese military scientists were brought on board. SARS had hit China. The CCP had been working at research already and was keen to benefit from importing state-of-the-art tech + science. Wuhan Institute of Virology ramped up world leading gain-of-function research and other key internationally sanctioned biological virus science.

    Coronavirus Research Summary

    • In most concise summary:
      • Gain-of-function banned in the US
      • Moved to Wuhan, China
      • Funded by NIH through Ecohealth (Fauci, Dahsak)
      • Wuhan lab used animals for research, including bats
      • In 2019, a novel coronavirus escaped from the Institute of Virology
      • Evidence of infection at World Military Games 2019
      • Major outbreak spread from Wuhan late 2019/early 2020
      • CCP couldn't contain it, despite authoritarian lockdown and early suppression
      • SARS-Cov2 novel coronavirus went worldwide
      • Covid-19, the disease created by SARS-Cov2, declared pandemic


    WHO Declares Pandemic Early 2020

    Early 2020. World Health Organisation declares pandemic. Coronavirus goes global. China shares viral genetic codes. Chinese scientists from the Wuhan lab register early Covid-19 vaccine patents along with Moderna and BioNtech-Pfizer.

    Wet Market Narrative Insertion

    Wet market narrative is inserted. China, WHO, CDC, US Govt and others are in lockstep with an official consensus: accidental coronavirus mutation from animals to humans went pandemic, no lab leak, lockdowns across the world to minimize infections, mass media husband public demand for vaccine ASAP.

    Operation Warp Speed - Dr Fauci - Big Tech

    • Dr Fauci and military Operation Warp Speed work aggressively to keep messaging consistent (and away from scrutiny of Wuhan Institute of Virology). China is also keen to suppress investigation.
    • Big Tech becomes weaponized to censor dissent from any source, scientist or layperson. YouTube, Twitter, Facebook, Google: hand in glove with government mandate.

    Vaccine Trials - Emergency Use Authorization

    • Trials of vaccines begin early/mid 2020. Stages become truncated to get the vaccines into play at unprecedented timescale.
    • By Stage III (late 2020) the mRNA vaccine trial studies have been designed from the outset to win FDA authorization and return very high efficacy. Authorization of these high-profile high-profit vaccines is pushed through fast. Emergency authorization terms require there to be no other COVID-19 treatment drugs.
    • Emergency Use Authorization of Medical Products and Related Authorities (2017): "For FDA to issue an EUA, there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition" i.e. hydroxychloroquine and ivermectin must stay unapproved and discredited.

    Based on data reported by the manufacturer for Pfzier/BioNTech vaccine BNT162b2, this critical appraisal shows: relative risk reduction, 95.1%; 95% CI, 90.0% to 97.6%; p = 0.016; absolute risk reduction, 0.7%; 95% CI, 0.59% to 0.83%; p < 0.000. For the Moderna vaccine mRNA-1273, the appraisal shows: relative risk reduction, 94.1%; 95% CI, 89.1% to 96.8%; p = 0.004; absolute risk reduction, 1.1%; 95% CI, 0.97% to 1.32%; p < 0.000. Unreported absolute risk reduction measures of 0.7% and 1.1% for the Pfzier/BioNTech and Moderna vaccines, respectively, are very much lower than the reported relative risk reduction measures. Reporting absolute risk reduction measures is essential to prevent outcome reporting bias in evaluation of COVID-19 vaccine efficacy.

    Big Pharma In Pursuit of Astronomical Profit

    • Big Pharma, having already entered into contracts to deliver billions of vaccine doses, spends millions on the groundwork - in mainstream media, government CDC, etc - to guide public pandemic expectations. They achieve unprecedented demand from national vaccine programs across the world.
    • Pfizer and Moderna (in particular) are focused on harvesting hundreds of billions of dollars profit, potentially trillions if their vaccines need to be taken every year.

    Trump and Biden In Pursuit of Political Advantage

    • Trump administration is both incompetent and luddite about coronavirus. When Covid-19 can no longer be ignored, Trump stubbornly doubles down on bullish politicized denialism, eschewing federalized strategy in favor of dropping organizing lockdown, quarantine, testing, treatment and vaccine deployment into the state by state red-v-blue internecine.
    • Establishment takes advantage of the Trump posture to arrange an opposing politics-led exclusive orthodoxy behind Fauci and CDC expertise: lockdowns, masks, censorship for public good, furloughs, vaccine programs, trillions of dollars transferred to corporate clients, etc.
    • Vaccine data, focus of media reportage, official bulletins from Fauci and then Biden administration continue the orthodox narrative. There's no let up on aggressive censorship of anything and anyone diverging from official CDC directive. Periodic numbers published about near-perfect efficacy of vaccines. Variants used to obfuscate closer inspection of data.

    Big Media in Pursuit of Clickbait Headlines

    Relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data are poorly understood by health professionals and the public. The absence of reported absolute risk reduction in COVID-19 vaccine clinical trials can lead to outcome reporting bias that affects the interpretation of vaccine efficacy.  What's more, trial data is limited by short time period reporting that don't take into account increase or decrease in efficacy outside the short window of back to back testing.


    Emergency Use Authorization

    • FDA emergency approval requires there to be no viable available treatment methods. This makes it essential to vaccine profit to squash ANY existing protocol (e.g. ivermectin + steroid + fluvoxamine blend) gaining official recognition. Censorship targets this line of public discussion consistent with Big Pharma/Big Tech/CDC strategy.
    • Alternative prophylaxis and treatment protocols for SARS-CoV2 and Covid-19 - like commonplace diet regimens, Ivermectin - are pushed out of the mainstream, publicly discredited despite growing evidence and clinician support. There's no profit from off-patent generics. Allowing zero profit medication to play a significant role as a Covid-19 treatment would reduce mRNA vaccine profits by literally tens of billions of dollars.


    Much media propagation of the NIH having concluded "there's currently insufficient data to recommend ivermectin for the treatment of COVID" i.e. don't use it, don't explore it. In fact, NIH current status on Ivermectin is there is not enough data to recommend or to discourage its use. NIH recommendation prior to December 2020 was to discourage Ivermectin usage. The change itself is significant and would usually be accompanied by a rush of funds to study its antiviral efficacy. No such funding has been forthcoming.

    Interestingly, two other COVID modalities have exactly the same recommend/discourage status. That would be remdesevir and outpatient monoclonal antibodies. EXACTLY the same status on both of these as ivermectin currently. The NIH states there is not enough evidence to recommend or to discourage the use of either of these. And yet we continue right on with both the others without a blink of an eye.

    A little maths –

    • Ivermectin course for COVID is less than twenty dollars.
    • A course of REMDESEVIR is currently right at 8800 dollars.
    • An outpatient treatment with monoclonal antibodies is right at 23000 – 25000 dollars with all the infusion costs added.


    Eventually, if things keeps looking, smelling and tasting like shit then we have to conclude it is shit.

    Big Pharmaceutical Corporations

    Moderna (m----RNA) in Cambridge MA start-up launched to monetize public-private partnership. Pfizer exclusive partnership with German funded BioNTech. AstraZeneca licenses Oxford University developed vaccine for Coronavirus with a zero-profit agreement.

    Trump Out - Democratic Biden In

    • Democratic Party has won Presidency, Senate, House of Reps. Big tech is playing ball. Big Pharma is making billions. Corporate America has emerged wealthier. They have dropped the economic hit this far on the middle and working class. Progressive opposition has been castrated.
    • Biden is distanced enough from Fauci, schmoozing abroad, playing up Putin and Chinese threat while business as usual plutocracy trundles into the second half of 2021.

    Lab Leak? Bioweapon? China's Evil Ambition?

    • There's no evidence Coronavirus was being weaponized by China or that its escape was planned. There's plenty of evidence Wuhan lab is the source, gain-of-function conditions bred the initial pandemic variant and China was working directly with America through Ecohealth, a front for the NIH/DARPA, run by Dr Fauci and his delegate Dr Dahsak.

    Vaccine Distribution: Apartheid? Logistics? Inevitable Divisions?

    Vaccine distribution is mostly under the control of the US (mRNA), the UK and India (AstraZeneca), with Russia and China rolling out its own vaccines using less advanced industrial scale technology. US Govt controls Pfizer/BioNtech and Moderna patents. UK Govt and UK/Swedish institutions probably control AstraZeneca patents. EU role is significant in production, probably less relevant in patent control.


    India is a major vaccine producer but its nationalist government has expelled the vaccine maker CEOs, hoarding stock for its own people; whose need is great.

    UK and US are the only autonomous advanced vaccine ecosystems. Both have horded homeland stock. US plays benevolent provider with one hand, price gouging hostage nations with the other.

    Bottom Line

    Trillions of Dollars

    Trillions of dollars are at stake, for corporate and treasury revenue, particularly in the United States and the United Kingdom/European Union. This will ensure American govt and its corporate clients will continue to exert their tight hold on the Coronavirus narrative.


    Expect censorship to continue, subjects diversifying according to government priority as directed by vaccine makers and political expedience. Big tech regulation is a stick to beat platforms into submission, taxation a clear and present penalty for forcing corporations or billionaire CEOs to play ball.


    Expect transgressions that risk profit or power to be punished with increasing force. Too much money and too many powerful people have staked their future on the current Coronavirus Political-Industrial complex. Expect genuine alternate prevention and treatment to be marginalized.  Will there be a paradigm shift? Look for testing standards that never coalesce and vaccine approval bias that continue to choose profit over lives e.g. American FDA not letting no-profit AstraZeneca ad-vector into the US market.



    Expect shifting standards in the media shilling for vaccine and vaccine mandates as efficacy data becomes less falsifiable real-world but maximum profit will inform the narrative e.g. if vax doesn't protect fully, look for propaganda about extra/regular shots, excuses like "the virus mutated" etc.



    American CDC Influenza Data (2018):

    World Health Organization Annual Influenza:

    Underbelly Timeline


    The Challenge of National Healthcare as President Truman takes on the American Medical Association in the aftermath of World War II.


    Anonymous "Conspiracy" Dossier on Coronavirus SARS-COV2, Peter Daszak Wuhan Virology, Fauci, the NIH/DARPA/Chinese CP Research Timelines


    Underinsurance has been a barrier to vaccination among children. Information on vaccination among adults ≥18 years by insurance status is limited. Purpose To assess vaccination coverage among adults ≥18 years in the United States in 2012 by health insurance status and access to care characteristics.


    Ecohealth Alliance Inc (Peter Daszak) ongoing provision of research grant payments for Bat Coronavirus Gain of Function work at the Wuhan Institute of Virology

    Mar-2020 to Feb-2021

    Small repository of documents and links relating to the Oxford University SARS-CoV2 vaccine and Bill Gates Foundation early negotiations


    Almost 50 million people (16%) population of the United States, live in rural areas, mainly low-to-moderate-income individuals. 65% of uninsured in rural areas live in States without ACA coverage


    The 21st Century Cures Act (Cures Act), signed into law on December 13, 2016, is designed to help accelerate medical product development and bring new innovations and advances to patients who need them faster and more efficiently. Ahem


    Studying the data about leading casues of death in metro and nonmetro areas of the United States 1999 and 2014 inclusive. Higher rates of death in nonmetropolitan areas (often referred to as rural areas) compared with metropolitan areas have been described


    Prefusion Coronavirus Spike Proteins NIH document - exemplar of going through the motions of appropriating the govt-funded mRNA vaccine technology and corollary patents, to enrich private business interests


    National Institutes of Health (NIH) today lifted a 3-year moratorium on funding gain-of-function (GOF) research on potential pandemic viruses such as avian flu, bat coronavirus, SARS, and MERS, opening the door for gain-of-function research to resume


    NIH has played a critical role in coronavirus research for decades. Federal scientists have helped fund, design, patent and test mRNA-1273 and others; vaccine candidates developed through Moderna and licensed to BioNTech (Germany) partnered with Pfizer Inc.


    Trusted News Initiative (TNI) brought to bear on news and internet media outlets, directed by government, ostensibly to combat so-called disinformation


    Scientists around the world are working to produce vaccines that can stop COVID-19. Since the emergence of this novel coronavirus in Dec 2019, 20 vaccines have started to be rolled out in countries worldwide.


    Archive exposing timeline of gain-of-function circumvention of laws, appropriation of public funds, US-China secret collaboration and pandemic mishandling